Pediatric starting doses and what to expect

Children and teens build up to the right dose of Qelbree in as soon as 1-3 weeks. Dosing is a journey, stick with it!

Building to an effective dose

The dose of Qelbree may be adjusted weekly as needed to optimize ADHD symptom control.*

Your healthcare provider will typically start your child on a lower dose and increase it gradually over the first 1-3 weeks until they reach the dose that’s right for them, adjusting as needed.

This could be anywhere from 100 mg to 400 mg per day for children and teens. This process is called titration.

*Your child’s healthcare provider will determine the dose based on your child’s response to medication.

Qelbree's titration schedule for children ages 6 to 11 starts at 100 mg/day and increases weekly up to a maximum of 400 mg/day. For teens ages 12 to 17, dosages start at 200 mg/day and increases to 400 mg/day. by week 4.

When to expect results

It’s important to know:

Qelbree is a non-stimulant medication and has a “gradual onset.” It could take a few weeks for the medication to be fully effective.

Qelbree provides a foundation of 24-hour coverage—avoiding peaks and crashes commonly experienced with most stimulant medications.

Qelbree is proven to work in medical studies that were conducted over 6 or 8 weeks—showing significant reduction in ADHD symptom scores in 4 medical studies of more than 1400 people.

Qelbree met the goal in the pediatric medical studies—a significant reduction in ADHD symptom scores in 6 or 8 weeks. Qelbree reduced ADHD symptom scores as early as Week 1 for some children.

Taking a week-by-week approach can help your child starting Qelbree

Managing your child’s ADHD is a journey. Here are some things you can do each week to help with their Qelbree experience when starting out.

Tasks for the first 3 weeks of treatment

It is important to keep all follow-up visits with your child’s healthcare provider and to monitor mood or behavior changes as well as any other side effects while they are taking Qelbree.

Stick with it!

Like many ADHD medications, reaching your child’s best daily dose of Qelbree may take some time. Make sure they stick with their treatment, and check in with your child and their healthcare provider about their progress.

If your child is still struggling with symptoms, or starts experiencing side effects, let their healthcare provider know. Sometimes, even small adjustments to their treatment dose can make a big difference.

Use the Qelbree Progress Tracker to help keep track of your experience as you find the right dose of Qelbree.

Qelbree Progress Tracker

Qelbree has helped us have a reset button where Eli is able to stop and process and think things through.”

Laura

Mother of son with ADHD
Paid spokesperson for Qelbree

See Eli and Laura’s story

49%

switched to Qelbree from a controlled substance or stimulant medication

51%

switched to Qelbree from other non‑stimulant ADHD meds

More tips for success

You’ve got this. Find more tips for success when starting your child on Qelbree.

Get more tips

INDICATION

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE